About Fermish Clinical Technologies Private Limited
Data last updated:
Fermish Clinical Technologies Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 19 January 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC132250. Its GSTIN is 07AABCF0166C1Z7 (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mumtaz Khan and Khalid Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2690 – B Kale Khan Street Kuchachelan Darya Ganj, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.66 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹31 Lakh (net margin 6.7%) and EBITDA of ₹57.34 Lakh (EBITDA margin 12.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 10% over five years.
The company is associated with 1 brand: Fermish. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fermish.com.
Company details
Contact details
Fermish Clinical Technologies Private Limited's registered office is in New Delhi, Delhi. Its website is fermish.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2690 – B Kale Khan Street Kuchachelan Darya Ganj, New Delhi, Delhi, India – 110002
- IndustryTravel and Hospitality, Consumer Professional Services
To see the full contact details of Fermish Clinical Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Fermish Clinical Technologies operates one associated brand: Fermish. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers regulatory submissions, medical writing, and compliance for pharma manufacturers. | fermish.com |
Business activity
The main business activity of Fermish Clinical Technologies is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Fermish Clinical Technologies Private Limited, buy the company report.
Financials of Fermish Clinical Technologies Private Limited
FY 2025 filings availableFermish Clinical Technologies Private Limited reported revenue of ₹4.66 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 411% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fermish Clinical Technologies Private Limited, buy the company report.
Board of directors of Fermish Clinical Technologies Private Limited
Fermish Clinical Technologies has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mumtaz Khan | Director | 19 Jan 2005 | 21 Years 9 Months | Current |
| Khalid Khan Also directs: Myt Technologies Private Limited | Director | 19 Jan 2005 | 21 Years 9 Months | Current |
Auditor
Fermish Clinical Technologies Private Limited is audited by BHARAT SHYAM & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHARAT SHYAM & ASSOCIATES | FY 2023 | 024926N |
Shareholding
The shareholding of Fermish Clinical Technologies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fermish Clinical Technologies Private Limited, buy the company report.
Legal cases
Fermish Clinical Technologies Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Civil suit | Filed against the company by M/S Shyam Spectra Private Limited | Disposed |
To see the full case history of Fermish Clinical Technologies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fermish Clinical Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fermish Clinical Technologies has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCF0166C1Z7 | Delhi | Active | 01 Jul 2017 |
| 09AABCF0166C1Z3 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fermish Clinical Technologies Private Limited, buy the company report.
Recent activity
Fermish Clinical Technologies Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Khalid Khan was appointed as Director on 19 Jan 2005.
Frequently asked questions
Fermish Clinical Technologies is an active private limited company based in New Delhi, Delhi, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 19 January 2005 (21+ years old) and is registered under CIN U24232DL2005PTC132250.
Fermish Clinical Technologies has 2 current directors:
- Mumtaz Khan - Director
- Khalid Khan - Director
The latest financial statements of Fermish Clinical Technologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Fermish Clinical Technologies is 07AABCF0166C1Z7, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AABCF0166C1Z3 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Fermish Clinical Technologies is U24232DL2005PTC132250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fermish Clinical Technologies has 1 court case on record: 1 filed against it.
Fermish Clinical Technologies was incorporated on 19 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Khalid Khan was appointed as Director on 19 Jan 2005. Mumtaz Khan was appointed as Director on 19 Jan 2005.
Fermish Clinical Technologies can be reached through the website fermish.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Fermish Clinical Technologies is at 2690 – B Kale Khan Street Kuchachelan Darya Ganj, New Delhi, Delhi, India – 110002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
